APLM

Apollomics, Inc. (APLMT) is a biotechnology company dedicated to developing innovative oncology therapies through a combination of monotherapy and targeted treatment approaches that harness the immune system and address specific molecular pathways in cancer management. Headquartered in Foster City, California, with additional operations in Hangzhou and Shanghai, China, as well as Southbank, Australia, Apollomics is strategically positioned to meet the increasing global demand for advanced cancer therapeutics. The company is committed to pioneering research that aims to tackle substantial unmet needs in the oncology landscape, with the potential to transform treatment paradigms and significantly enhance patient outcomes.